Peptide Drug Development Services
Product
Information
ResolveMass Laboratories offers comprehensive Peptide Drug Development Services designed to support pharmaceutical companies navigating the complex regulatory and analytical landscape of peptide-based therapeutics. Our expertise spans the full lifecycle of peptide injectable development, including long-acting injectable (LAI) formulations, which demand rigorous characterization due to their complex release profiles and structural sensitivity. At the core of our peptide development offering is end-to-end characterization — from primary sequence confirmation and higher-order structural analysi...
Distribution Areas
North America (USA, Canada)Middle East Region (e.g. UAE)Central America (e.g. Mexico)Europe - EU countriesEurope - non EU (e.g. UK, Russia, ex-CIS countries)South America (e.g. Brazil, Colombia)South Asia (e.g. India, Pakistan, Sri Lanka)
Supplied From
Canada
Main Categories
Biopharmaceutical ProductsContract Development and Manufacturing Organisations (CDMOs) and Contract Manufacturing Organisations (CMOs) (Services)Innovative APIsBiopharmaceutical ServicesContract Research Organisations (CROs) (Services)
All Categories
PeptidesGeneric PeptidesAnalytical Methods (Biopharmaceutical Services)Medicinal Chemistry (Biopharmaceutical Services)Analytical DevelopmentBio Analytical ServicesAntibody Drug Conjugates (ADCs)
